Humanized In Vivo Bone Tissue Engineering: In Vitro Preculture Conditions Control the Structural, Cellular, and Matrix Composition of Humanized Bone Organs
- PMID: 39444080
- PMCID: PMC11729988
- DOI: 10.1002/adhm.202401939
Humanized In Vivo Bone Tissue Engineering: In Vitro Preculture Conditions Control the Structural, Cellular, and Matrix Composition of Humanized Bone Organs
Abstract
Bone tissue engineering (BTE) has long sought to elucidate the key factors controlling human/humanized bone formation for regenerative medicine and disease modeling applications, yet with no definitive answers due to the high number and co-dependency of parameters. This study aims to clarify the relative impacts of in vitro biomimetic 'preculture composition' and 'preculture duration' before in vivo implantation as key criteria for the optimization of BTE design. These parameters are directly related to in vitro osteogenic differentiation (OD) and mineralization and are being investigated across different osteoprogenitor-loaded biomaterials, specifically fibrous calcium phosphate-polycaprolactone (CaP-mPCL) scaffolds and gelatin methacryloyl (GelMA) hydrogels. The results show that OD and mineralization levels prior to implantation, enhanced by a mineralization medium supplement to the osteogenic medium (OM), significantly improve ectopic BTE outcomes, regardless of the biomaterial type. Specifically, preculture conditions are pivotal in achieving more faithful mimicry of human bone structure, cellular and extracellular matrix composition and organization, and provide control over bone marrow composition. This work emphasizes the potential of using biomimetic culture compositions, specifically the addition of a mineralization medium as a cost-effective and straightforward approach to enhance BTE outcomes, facilitating rapid development of bone models with superior quality and resemblance to native bone.
Keywords: bone structure; bone tissue engineering (BTE); extracellular matrix; humanized mouse model; in vivo bone model; mineralization; osteogenic differentiation (OD).
© 2024 The Author(s). Advanced Healthcare Materials published by Wiley‐VCH GmbH.
Conflict of interest statement
D.W.H. is a co‐founder and shareholder of GELOMICS PTY LTD, a Brisbane‐based company developing and distributing hydrogels for 3D cell culture applications. All other authors declare no competing interests.
Figures








Similar articles
-
Gelatin methacrylate scaffold for bone tissue engineering: The influence of polymer concentration.J Biomed Mater Res A. 2018 Jan;106(1):201-209. doi: 10.1002/jbm.a.36226. Epub 2017 Sep 28. J Biomed Mater Res A. 2018. PMID: 28884519
-
Fabrication of Mechanically Reinforced Gelatin/Hydroxyapatite Bio-Composite Scaffolds by Core/Shell Nozzle Printing for Bone Tissue Engineering.Int J Mol Sci. 2020 May 11;21(9):3401. doi: 10.3390/ijms21093401. Int J Mol Sci. 2020. PMID: 32403422 Free PMC article.
-
Hydrogel composite scaffolds with an attenuated immunogenicity component for bone tissue engineering applications.J Mater Chem B. 2021 Mar 4;9(8):2033-2041. doi: 10.1039/d0tb02588g. J Mater Chem B. 2021. PMID: 33587079
-
Decellularized Extracellular Matrix Scaffolds: Recent Advances and Emerging Strategies in Bone Tissue Engineering.ACS Biomater Sci Eng. 2024 Dec 9;10(12):7372-7385. doi: 10.1021/acsbiomaterials.4c01764. Epub 2024 Nov 4. ACS Biomater Sci Eng. 2024. PMID: 39492720 Review.
-
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels.Biomaterials. 2015 Dec;73:254-71. doi: 10.1016/j.biomaterials.2015.08.045. Epub 2015 Aug 28. Biomaterials. 2015. PMID: 26414409 Free PMC article. Review.
References
-
- Xu C., Liu Z., Chen X., Gao Y., Wang W., Zhuang X., Zhang H., Dong X., Chin. Chem. Lett. 2024, 35, 109197.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous